Stockreport

SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing

SOPHiA GENETICS SA - Ordinary Shares  (SOPH) 
PDF The companies commit to bring cutting-edge liquid biopsy testing to 20 institutions globally over the next 12 monthsBOSTON and ROLLE, Switzerland, Sept. 10, 2024 /PRNews [Read more]